RXplore: New Regenstrief tool lets docs instantly track down drug reactions

Apr 12, 2010
Jon D. Duke, M.D., is with the Regenstrief Institute and Indiana University School of Medicine. Credit: Jon D. Duke, M.D.

It's not uncommon for individuals to take as many as a dozen different prescriptions, each with its own set of possible side effects. If a patient experiences one of the potential hundreds of different adverse reactions such as nausea, headaches, insomnia or heart palpitations, how does the physician quickly and accurately determine which drug is the culprit?

Jon D. Duke, M.D., a medical informatics fellow at the Regenstrief Institute and the Indiana University School of Medicine, has created an easy-to-use graphical tool called RXplore which expedites tracking down the cause of . His work is published in the April 2010 issue of the Journal of Biomedical Informatics.

Currently doctors depend on knowledge of acquired from past experience or by reviewing published prescribing information either online or in print. When evaluating multiple drugs the physician must look up each medication one at a time, a time-consuming process made more difficult by the dense and complex text found in typical drug labels.

RXplore solves this problem in a novel manner allowing physicians and other health-care providers to retrieve adverse reaction data for multiple medications simultaneously with an intuitive . An evaluation study showed that physicians are able to retrieve accurate side-effect information 65 percent faster using Rxplore than when using traditional drug information resources.

This video is not supported by your browser at this time.

"Patients on complex drug regimens are doubly disadvantaged. They are at increased risk for an adverse event, yet their physician may be less likely to perform a thorough review of their medications due to the lengthy time required," said Dr. Duke.

He notes that he came up with the concept of visualizing drug data but soon found that labels were inconsistent in how adverse events were reported. The greatest challenge of this project, according to Dr. Duke, was devising a system to represent such varied information in a consistent way.

How, for instance, can a "rare" occurrence and an "infrequent" one be compared? How do you contrast a numerical value - greater than three percent of patients have a certain side effect - to a phrase such as patients "sometimes" have this side effect?

"Once we had done the heavy lifting of building the framework and models, we were able to develop the "eye candy" - the visualization that the doctor sees," he said.

With RXplore a physician can easily call up a visualization of the top 10 side effects of a specific drug or ask only for side effects relating to a particular specialty such as gastroenterology. Alternatively the doctor may request a snapshot of those drugs which cause a particular symptom, such as liver problems.

Answering such questions with RXplore took less than a minute and testers reported unanimously that they preferred the new tool to what they previously used to determine drug effects.

"Our next step is to begin gathering data on how the interactions of multiple medicines affect the likelihood of experiencing a side effect. This is not as simple as it sounds. If, for example, you take three drugs, each with a 4 percent risk of nausea, you don't have a 12 percent risk of nausea - it can be higher or lower. Genetics also come into play in considering the likelihood of a side effect, as do concurrent illnesses. When evaluating drug side-effects, we must begin thinking beyond individual medicines and consider a patient as a whole," says Dr. Duke.

Explore further: Xtoro approved for swimmer's ear

Provided by Indiana University School of Medicine

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

The Medical Minute: Talk about prescriptions

Oct 28, 2009

Look in your wallet, purse, personal digital assistant or smart phone and you probably have a list of names, phone numbers and addresses. You might even have a file for your passwords or important account numbers, birthdays ...

Tips to prevent adverse drug events in older adults

Jan 02, 2008

Adverse drug events are more common in older adults because they are prescribed more drugs and are effected differently by these drugs than their younger counterparts. A review article written by Tufts University School of ...

Recommended for you

Xtoro approved for swimmer's ear

16 hours ago

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

17 hours ago

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.